OBOsman Cagin Buldukoglu

Osman Cagin Buldukoglu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Osman Cagin Buldukoglu has a total of 413 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pancreatic Steatosis: Innocent Bystander or Silent Culprit?

    by Ahmet Sukru Alparslan, Ruhsen Ocal, Osman Cagin Buldukoglu, Serdar Akca, Berna Ozcanoglu, Mert Van, Galip Egemen Atar, Serkan Ocal, Ayhan Hilmi Cekin

    Background/Aims: Pancreatic steatosis (PS) is characterized by fat accumulation within the pancreas and is associated with chronic low-grade inflammation. Migraine, the third most commonly seen disease worldwide, is an established risk factor for white matter lesions (WMLs). Given the shared inflammatory background of these conditions, it was hypothesized that the presence of PS in patients with migraine may contribute to the development of WMLs. Materials and Methods: This cross-sectional study included patients with migraine who attended the outpatient clinic and had undergone cranial magnetic resonance imaging (MRI) scan for any indication within the last 6 months. Following MRI, patients were referred to the radiology department for transabdominal ultrasonography to assess the presence of PS and hepatosteatosis. Results: Among the 78 patients with migraine included in the study, 35 (44.9%) had cranial WMLs. PS was significantly more prevalent among patients with WMLs than among those without WMLs (57.4% vs. 16.7%, P < .001). In multivariable logistic regression analysis adjusted for age, body mass index, and low-density lipoprotein/high-density lipoprotein ratio, PS remained independently associated with cranial WMLs (odds ratio (OR) 5.79, 95% CI 1.004-33.41; P = .049). Increasing age was also independently associated with WMLs (OR 1.095 per year, 95% CI 1.018-1.179; P = .015). Conclusion: This study demonstrated that the presence of PS may contribute to disease burden in patients with migraine. Evaluation of PS in this population may help identify a potentially modifiable metabolic condition and provide additional insight into the management of this common and debilitating disorder. Cite this article as: Alparslan AS, Ocal R, Buldukoglu OC, et al. Pancreatic steatosis: Innocent bystander or silent culprit? Turk J Gastroenterol. Published online July 20, 2026. doi:10.5152/tjg.2026.26091.

  • Open Access

    Comment on Machine Learning–Based Prediction of Histopathological Classification in Colorectal Polyps

    by Serdar Akca, Osman Cagin Buldukoglu, Galip Egemen Atar, Ayhan Hilmi Cekin

    Cite this article as: Akca S, Buldukoglu OC, Atar GE, Cekin AH. Comment on machine learning–based prediction of histopathological classification in colorectal polyps. Turk J Gastroenterol. Published online February 20, 2026. doi: 10.5152/tjg.2026.25816.

  • Open Access

    Guidelines vs. generative AI in CKD patient education: the role of prompt engineering and expert blinded evaluation

    by Lutfullah Zahit Koc, Sevgi Gulsen Koc, Ayca Inci, Osman Cagin Buldukoglu, Gokhan Koker, Edgar V. Lerma

    This study aimed to evaluate the accuracy, content quality, and readability of patient education responses related to chronic kidney disease (CKD) generated by large language models (ChatGPT-4o mini and Gemini) compared to guideline group. Fifteen frequently asked CKD-related questions were selected using global Google Trends data and posed to both AI models and guideline-based sources. Responses were anonymized and evaluated by four independent nephrology professors using the CLEAR Tool, assessing completeness, appropriateness, evidence basis, and clarity. Both AI models significantly outperformed guideline responses across all CLEAR Tool domains (p < 0.001), with ChatGPT-4o mini achieving the highest median score (21.0 [IQR: 5.0] vs. Gemini: 17.0 [IQR: 5.0], Guideline: 13.0 [IQR: 2.0]). Initial readability analysis showed that guideline responses were easier to comprehend (Flesch-Kincaid Grade Level (FKGL): 9.40; Flesch Reading Ease (FRE): 52.01) than AI-generated content (ChatGPT FKGL: 11.34, FRE: 36.17; Gemini FKGL: 9.62, FRE: 46.36). However, when a structured prompt was applied, AI responses demonstrated significant improvements in readability, reducing the required literacy level to approximately the 7th-grade (ChatGPT FKGL: 7.87, FRE: 64.23; Gemini FKGL: 7.13, FRE: 61.45). These findings highlight the potential of prompt-guided AI models to generate accurate, accessible educational content for CKD. Prompt engineering emerges as a practical tool to enhance clarity and usability, particularly for populations with limited health literacy. Integration with frameworks like Retrieval-Augmented Generation may further improve reliability and safety in digital health communication.


  • Open Access

    Gastroenteroloji Textbook - Cilt (1-2)

    by Alper Macif, Ahmed Ramiz Baykan, Gökhan Çoban, Sadık Yavuz, Berk Bas, Mehmet Kasım Aydın, Selçuk Candan, Fatih Güzelbulut, Atilla Bulur, Fatih Ensaroğlu, et al.

  • Open Access

    Kilo Kaybı

    by Osman Çağın Buldukoğlu, Ozan Cengiz

    İstemsiz kilo kaybı pek çok farklı klinik duruma ikincil gelişebilen önemli bir semptomdur. Altta yatan sebep hafif hastalık tablolarından ileri evre kanserlere kadar değişkenlik gösterebildiği için hızlı tanı önemlidir. Hasta öyküsü, fizik muayene bulguları ve ileri laboratuar ve görüntüleme teknikleri ile tanı konulan vakalarda altta yatan etkenin düzeltilmesi temel tedaviyi oluşturur. Gastrointestinal sistem hastalıklarına sıklıkla eşlik eden istemsiz kilo kaybı, günlük pratikte sık karşılaşılan, önemli bir semptomdur.

  • Open Access

    Utility of hematological parameters in predicting the severity and course of acute gallstone pancreatitis

    by Osman Çağın Buldukoğlu, Serkan Öcal, Beşir Kaya, Galip Egemen Atar, Serdar Akça, Ferda Harmandar, Ayhan Hilmi Çekin

    Background and Aims: Acute pancreatitis is a serious disorder which can lead to severe organ failure and mortality. Early predictors of severe disease course is crucial in the decision making process of the healthcare team. Complete blood count, or hemogram, is a commonly used laboratory test in daily clinical practice. The aim of this study is to define a potential predictive biomarker for acute gallstone pancreatitis amongst the parameters evaluated in complete blood count, hence identifying patients with risk of unfavorable outcomes through an easy-to-use serum marker. Materials and Methods: 233 acute pancreatitis patients secondary to gallstones were evaluated retrospectively. Patient data was gathered from hospital registry system and patient records recorded prospectively at the time of admission. Hematological parameters were compared with severity scoring systems for acute pancreatitis and disease outcomes. Results: White blood cell counts and neutrophil-lymphocyte ratio were correlated with severity scoring systems. Neutrophil-lymphocyte ratio was correlated with a longer hospitalization time and a cut-off point of 5 was found to be useful in predicting disease course. Conclusion: Hematological parameters, particularly neutrophil-lymphocyte ratio, are promising predictive biomarkers for acute gallstone pancreatitis severity.

  • Open Access

    Relationship of coffee consumption with colonic diverticulosis

    by Osman Cagin Buldukoglu, Serkan Ocal, Serdar Akca, Galip Egemen Atar, Ferda Akbay Harmandar, Ayhan Hilmi Cekin

    Diverticulosis is the most common benign pathology of the colon. Genetics, inflammation, neuromuscular abnormalities, colonic motility and lifestyle including dietary habits play roles in disease pathogenesis. Coffee is one of the most commonly consumed beverages worldwide and exerts antiinflammatory functions in the human body as well as affecting colonic motility and neuromuscular physiology of the gastrointestinal system. Therefore, this study was planned to investigate the relationship between coffee consumption and diverticulosis. A total of 1669 patients undergoing colonoscopy was enrolled in this cross-sectional study over a span of one year. Data from the patients was gathered through a questionnaire and matched with colonoscopy results. Coffee consumption was evaluated both as total cups of coffee consumed regardless of subtype per day and individual consumption of subtypes which were designated as instant coffee (Nescafe), Turkish coffee and brewed coffee (referred to as machine coffee in Turkey). Overall coffee consumption regardless of subtype was not found to be related to diverticulosis. Multivariate logistic regression analysis revealed age and non-steroid antiinflammatory drug usage were risk factors for diverticulosis with odds ratios of 1.062 and 1.645 respectively. Regular exercise was found to be related with lower rates of colonic diverticulosis with an odds ratio of 0.684. Coffee consumption be it total sum or specific subtypes or caffeine intake were not found to be statistically significantly related to diverticulosis in multivariate logistic regression analysis. This study revealed that coffee intake or caffeine intake does not increase the risk of colonic diverticulosis. Further research may explore whether different coffee types have varying effects.


  • Open Access

    Etrasimod in Treatment of Ulcerative Colitis: A Comprehensive Review

    by Osman Cagin Buldukoglu, Yusuf Erzin, Ayhan Hilmi Cekin, Silvio Danese

    Ulcerative colitis (UC) is a chronic, inflammatory disease of the colon. The unpredictable, systemic, and debilitating nature of UC puts disease management and patient monitoring at a pivotal point. Despite substantial development in pharmacotherapies for UC in recent years, a significant proportion of patients either fail to respond to treatment or lose their response over the course of the disease. The backbone of disease management in UC is 5-aminosalicylic acid (5-ASA), but patients unresponsive to 5-ASA or with severe disease require advanced therapies including tumor necrosis factor-alpha inhibitors (TNFi), anti-integrins, anti-interleukins and small molecule therapy, Janus kinase (JAK) inhibitors, and S1PR modulators. This review will briefly overview the current state of medical therapeu tic options in UC, with further detailing the molecular and clinical aspects of Etrasimod, a sphingosine-1-phosphate receptor (S1PR) modulator. Cite this article as: Buldukoglu OC, Erzin Y, Cekin AH, Danese S. Etrasimod in treatment of ulcerative colitis: A comprehensive review. Turk J Gastroenterol. 2025;36(6):336-342.


  • Open Access

    A novel inflammatory biomarker in assessing disease activity in ulcerative colitis: gasdermin D

    by Osman Cagin Buldukoglu, Serkan Ocal, Serdar Akca, Galip Egemen Atar, Besir Kaya, Muhammet Devran Isik, Ozlem Koca, Ferda Akbay Harmandar, Yesim Cekin, Ayhan Hilmi Cekin

    Ulcerative colitis (UC) is a chronic inflammatory disease with a worldwide prevalance of around 5 million patients. Assessment of disease activity is crucial in management of UC patients. Gasdermin D (GSDMD) is a protein which belongs to the gasdermin protein family and plays a role in inflammatory cell death, pyroptosis. GSDMD activation has been shown to be related to inflammatory states in a variety of disorders, including inflammatory bowel diseases. With this study, we aimed to reveal a potential new inflammatory serum marker for assessing disease activity and severity in UC patients in a non-invasive manner. This prospective study was carried out at Antalya Training and Research Hospital, Turkey, between September 2022 and March 2024. 93 UC patients were enrolled in the study. Patient and disease characteristics, laboratory workout data, and severity indexes comprising Truelove and Witts’ severity index (TWSI) and Mayo endoscopic subscore (MES) were analyzed with serum GSDMD levels. GSDMD, CRP (C-reactive protein), and body-mass index were statistically significant independent predictors of increasing disease severity according to TWSI. GSDMD and CRP were statistically significant independent predictors of higher MES scores. GSDMD demonstrated excellent discriminative performance in distinguishing patients with moderate-to-severe MES from those with normal or mild MES, with an area under the curve value of 0.976. A cut-off value of 6.0 ng/mL for GSDMD was identified as optimal, yielding a sensitivity of 95.0%, a specificity of 86.3%, and a Youden Index of 0.813. The results of the study revealed that GSDMD is a robust biomarker in predicting a more severe disease state for UC in terms of TWSI and MES, putting this novel protein into highlight as a potential new biomarker in patients with UC.


  • Open Access

    Gasdermin D: A New Inflammatory Biomarker in Assessing Clinical Disease Activity in Crohn’s Disease

    by Osman Cagin Buldukoglu, Serkan Ocal, Galip Egemen Atar, Besir Kaya, Muhammet Devran Isik, Gul Aydin Tigli, Serdar Akca, Ferda Akbay Harmandar, Yesim Cekin, Ayhan Hilmi Cekin

    Background/Aims: Crohn’s disease (CD) is an inflammatory, progressive disorder requiring monitoring of treatment response and disease course. Gasdermin D (GSDMD), a protein belonging to the gasdermin protein family, plays a role in inflammatory cell death, and activation of GSDMD has been shown to be a component of the pathogenesis of inflammatory bowel disease. Considering the role that GSDMD plays in inflammation, it was hypothesized that disease activity in CD may be correlated with serum GSDMD levels. The aim of this study was to assess the strength of GSDMD in predicting clinical disease activity in patients with CD in a prompt and easy manner. Materials and Methods: This cross-sectional study was conducted over a span of 22 months from September 2022 to June 2024. A total of 61 patients with CD were included in the study. Demographic data, disease- and treatment-related data, and laboratory workups of the patients were recorded and analyzed. Results: Gasdermin D levels were statistically significant in their correlation with the Harvey–Bradshaw Index (HBI) scores of the study population (P = .019). A threshold value of 5 ng/mL for GSDMD had a sensitivity of 84.6% and a specificity of 91.7% in differentiating patients with remission or mild disease from those with moderate or severe disease, according to HBI. Conclusion: This pioneering study revealed that serum GSDMD can be used as a biomarker to assess clinical disease activity in patients with CD. Future studies incorporating colonoscopic evaluation into the equation will provide more insight into the use of this protein as a surrogate marker of disease progression in CD. Cite this article as: Buldukoglu OC, Ocal S, Atar GE, et al. Gasdermin D: A new inflammatory biomarker in assessing clinical disease activity in Crohn’s disease. Turk J Gastroenterol. 2025;36(9):556-562.